Jessica Hope Roark

Array ( [id] => 8489088 [patent_doc_number] => 20120288495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'THERAPEUTIC COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/384981 [patent_app_country] => US [patent_app_date] => 2010-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12505 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8198160 [patent_doc_number] => 20120122122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'METHOD OF DIAGNOSING CANCER' [patent_app_type] => utility [patent_app_number] => 13/384973 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8687 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122122.pdf [firstpage_image] =>[orig_patent_app_number] => 13384973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8464555 [patent_doc_number] => 20120269723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'COMPLEX OF BI-SPECIFIC ANTIBODY AND DIGOXIGENIN CONJUGATED TO A THERAPEUTIC OR DIAGNOSTIC AGENT' [patent_app_type] => utility [patent_app_number] => 13/382502 [patent_app_country] => US [patent_app_date] => 2010-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 104 [patent_figures_cnt] => 104 [patent_no_of_words] => 46251 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10006877 [patent_doc_number] => 09050375 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'Bi-specific digoxigenin binding antibodies' [patent_app_type] => utility [patent_app_number] => 13/382505 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 103 [patent_figures_cnt] => 188 [patent_no_of_words] => 45872 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8208923 [patent_doc_number] => 20120128586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'METHOD FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA' [patent_app_type] => utility [patent_app_number] => 13/377514 [patent_app_country] => US [patent_app_date] => 2010-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12427 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128586.pdf [firstpage_image] =>[orig_patent_app_number] => 13377514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290373 [patent_doc_number] => 20120178698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'Agents and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/378805 [patent_app_country] => US [patent_app_date] => 2010-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 21686 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026095 [patent_doc_number] => 08535674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Treating breast cancer and inhibiting cancer-associated bone loss with anti-IL-20 antibody' [patent_app_type] => utility [patent_app_number] => 12/815855 [patent_app_country] => US [patent_app_date] => 2010-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5235 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12815855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8431143 [patent_doc_number] => 20120253017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'STEM CELL TARGETING' [patent_app_type] => utility [patent_app_number] => 13/322030 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 121 [patent_figures_cnt] => 121 [patent_no_of_words] => 39047 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9233018 [patent_doc_number] => 08598322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-03 [patent_title] => 'Anti CEACAM1 antibodies and methods of using same' [patent_app_type] => utility [patent_app_number] => 13/318266 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 10041 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13318266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9112885 [patent_doc_number] => 08569055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Identification and characterization of cancer stem cells and methods of use' [patent_app_type] => utility [patent_app_number] => 12/768607 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 12072 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12768607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234682 [patent_doc_number] => 20100266495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Anti-Cancer Activity of an Anti-Thymidine Kinase Monoclonal Antibody' [patent_app_type] => utility [patent_app_number] => 12/767489 [patent_app_country] => US [patent_app_date] => 2010-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11978 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266495.pdf [firstpage_image] =>[orig_patent_app_number] => 12767489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8197053 [patent_doc_number] => 20120121596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'BISPECIFIC ANTI-HER ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/257519 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 49790 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121596.pdf [firstpage_image] =>[orig_patent_app_number] => 13257519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10838197 [patent_doc_number] => 08865873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Internalizing human monoclonal antibodies targeting prostate cancer cells in situ' [patent_app_type] => utility [patent_app_number] => 12/724282 [patent_app_country] => US [patent_app_date] => 2010-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 26880 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12724282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202993 [patent_doc_number] => 20110065779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'AAV VECTOR COMPOSITIONS AND METHODS FOR ENHANCED EXPRESSION OF IMMUNOGLOBULINS USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/718069 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17497 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065779.pdf [firstpage_image] =>[orig_patent_app_number] => 12718069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663865 [patent_doc_number] => 20110313134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'ENGINEERED ANTIBODIES WITH REDUCED IMMUNOGENICITY AND METHODS OF MAKING' [patent_app_type] => utility [patent_app_number] => 13/128127 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13569 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313134.pdf [firstpage_image] =>[orig_patent_app_number] => 13128127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6577495 [patent_doc_number] => 20100047285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'ANTICANCER AGENTS USING VEROTOXIN VARIANTS' [patent_app_type] => utility [patent_app_number] => 12/580026 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10881 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047285.pdf [firstpage_image] =>[orig_patent_app_number] => 12580026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499429 [patent_doc_number] => 20110262436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'TREATMENT METHOD' [patent_app_type] => utility [patent_app_number] => 13/124486 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 50226 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262436.pdf [firstpage_image] =>[orig_patent_app_number] => 13124486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493699 [patent_doc_number] => 20100209438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'OVR110 Antibody Compositions and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/576313 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 45765 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209438.pdf [firstpage_image] =>[orig_patent_app_number] => 12576313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070132 [patent_doc_number] => 20110044982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'MULTIFUNCTIONAL LINKER PROTEIN CONTAINING AN ANTIBODY AGAINST HEMAGGLUTININ, A CONSERVED INFLUENZA ANTIGEN AND AN IMMUNOSTIMULATING CARRIER BINDING DOMAIN' [patent_app_type] => utility [patent_app_number] => 12/989886 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7484 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044982.pdf [firstpage_image] =>[orig_patent_app_number] => 12989886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254847 [patent_doc_number] => 08618264 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Anti-CD147 antibodies, methods and uses' [patent_app_type] => utility [patent_app_number] => 13/062702 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19185 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13062702 [rel_patent_id] =>[rel_patent_doc_number] =>)